Bioregenx (BRGX) Change in Receivables (2023 - 2026)
Bioregenx's quarterly Change in Receivables came in at -$21335.0 in Q1 2026, down 456.03% year-on-year from $5992.4 in Q1 2025, and up 6.8% quarter-over-quarter from -$22892.0 in Q4 2025.
Bioregenx has reported Change in Receivables for 4 years, with the latest figure at -$21335.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Receivables fell 456.03% year-over-year to -$21335.0; the trailing twelve-month figure through Mar 2026 stood at $7228.0 (up 36240.0% YoY), and the FY2025 full-year result was $24726.0, up 127.6% from the prior year.
- Change in Receivables for Q1 2026 stood at -$21335.0, up from -$22892.0 in the prior quarter.
- The five-year high for Change in Receivables was $41495.0 in Q3 2025, with the low at -$93406.0 in Q1 2024.
- Average Change in Receivables over 4 years is -$5004.3, with a median of -$232.0 recorded in 2024.
- Year-over-year, Change in Receivables sank 482.15% in 2024 and surged 4393.1% in 2025.
- Tracing BRGX's Change in Receivables over 4 years: stood at $22584.0 in 2023, then tumbled by 119.7% to -$4450.0 in 2024, then slumped by 414.43% to -$22892.0 in 2025, then rose by 6.8% to -$21335.0 in 2026.
- The last three Change in Receivables figures came in at -$21335.0 (Q1 2026), -$22892.0 (Q4 2025), and $41495.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | 945.72 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 114.13 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | -1.69 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | 48.86 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | -11.72 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | -3.24 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | -18.13 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | 112.77 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 33.30 Mn |
| 10 | Bioregenx | - | - | 348,288.00 | -21,335.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21,335.00 |
| Mar 31, 2026 | -21,335.00 |
| Dec 31, 2025 | -22,892.00 |
| Dec 31, 2025 | -22,892.00 |
| Sep 30, 2025 | 41,495.00 |
| Sep 30, 2025 | 41,495.00 |
| Jun 30, 2025 | 9,960.00 |
| Jun 30, 2025 | 9,960.00 |
| Mar 31, 2025 | -3,837.00 |
| Mar 31, 2025 | -3,837.00 |
| Dec 31, 2024 | -4,450.00 |
| Dec 31, 2024 | -4,450.00 |
| Sep 30, 2024 | 8,499.00 |
| Sep 30, 2024 | 8,499.00 |
| Jun 30, 2024 | -232.00 |
| Jun 30, 2024 | -232.00 |
| Mar 31, 2024 | -93,406.00 |
| Mar 31, 2024 | -93,406.00 |
| Dec 31, 2023 | 22,584.00 |
| Dec 31, 2023 | 22,584.00 |
| Sep 30, 2023 | 1,442.00 |
| Sep 30, 2023 | 1,442.00 |
| Jun 30, 2023 | -27,326.00 |
| Jun 30, 2023 | -27,326.00 |
| Mar 31, 2023 | 24,442.00 |
| Mar 31, 2023 | 24,442.00 |